Lv5
1270 积分 2022-10-15 加入
Efficacy and safety of zanubrutinib combined with chimeric antigen receptor T-cell therapy targeting CD19 in refractory or relapsed diffuse large B cell lymphoma: A retrospective analysis
10小时前
已完结
Ibrutinib治疗慢性淋巴细胞白血病研究进展
13天前
已关闭
[18F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy
1个月前
已完结
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma
2个月前
已完结
Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking
2个月前
已完结
Dual targeting CAR-T cells for B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin lymphoma
3个月前
已关闭
Dual targeting CAR-T cells for B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin lymphoma
3个月前
已关闭
Targeting cytohesin-1 suppresses acute myeloid leukemia progression and overcomes resistance to ABT-199
4个月前
已完结
Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer
4个月前
已完结
流式细胞术在嵌合抗原受体-T细胞免疫治疗相关检验中的应用专家共识
5个月前
已完结
皖公网安备34019202002308
